In 2017, the World Health Organization recognized Togo for eliminating lymphatic filariasis as a public problem in the country. Togo is the first country in Africa to receive WHO validation for elimination of the disease.
Togo was validated by the WHO as having eliminated trachoma as a public health problem in May 2022.
Togo will perform additional investigations—specifically skin snip polymerase chain reactions (PCR) for onchocerciasis—in the Savane regions following the stop MDA survey conducted in 2022.
Togo will be the first country to have implemented nationwide sub-district MDA for schistosomiasis/soil-transmitted helminthiasis (SCH/STH) starting in 2010. Since then Togo is also the first country to have completed their second nationwide SCH/STH impact assessment in 2024 (the first was in 2015). Togo was also one of four countries in West Africa selected by the Task Force for Global Health to conduct a SCH Oversampling survey in three districts in 2022. The data from these surveys conducted between 2021 and 2024 will be used to implement a new treatment strategy for 2024.
Togo is one of the first countries to conduct annual community-based mass drug administration (MDA) for soil-transmitted helminths (STH) and schistosomiasis (SCH) at the sub-district level. Togo conducted its second re-assessment survey in 2021 among 93 sub-districts to review the impact of multiple rounds of high coverage MDA.
Standard Disease-Specific Indicators as of FY21
FY21 is October 2020 through September 2021